PRO-INFLAMMATORY ACTIVATION OF MONOCYTES IN PATIENTS WITH IMMUNOINFLAMMATORY RHEUMATIC DISEASES



Cite item

Full Text

Abstract

Abstract

The development of subclinical atherosclerosis in patients with rheumatoid arthritis (RA) is associated with chronic inflammation, one of the key mechanisms of which may be abnormal activation of macrophages.

Objective: To assess the characteristics of pro-inflammatory activation of circulating monocytes in patients with early RA depending on the presence of subclinical atherosclerosis of the carotid arteries.

Material and methods: The study included 60 patients (42 women and 18 men) with early RA without signs of cardiovascular disease. Atherosclerotic vascular disease was diagnosed by identifying carotid atherosclerotic plaques. Basal and stimulated monocyte lipolysaccharide (LPS) secretion was studied in initial monocyte cultures obtained by immunomagnetic separation from blood. Quantification of the cytokines TNF-α and IL-1β was obtained in the culture fluid by ELISA. Proinflammatory activation of monocytes was calculated as the ratio of LPS-stimulated and basal secretion.

Results: Atherosclerotic plaques of the carotid arteries were found in a third of RA patients; they were detected more often in men (50%) than in women (26%, p <0.05). The carotid thickness of the intima media complex correlated with the level of total cholesterol (R = 0.20; p = 0.001) and ESR (R = 0.31; p = 0.03).

In RA patients and subclinical carotid atherosclerosis, cultured blood monocytes demonstrated higher basal TNF-α secretion (294.6 [185.3; 778.2] vs 146.1 [27.9; 79.9] pg/ml, p < 0.01) and low activation of TNF-α (9.5 ± 2.1 versus 19.8 ± 3.9, p < 0.001) and IL-1β (6.1 ± 2.3 versus 9.5 ± 1.8, p = 0.03) compared with patients without lesions of the carotid arteries. In RA patients with carotid atherosclerotic plaques, a relationship was found between LPS-stimulated IL-1β secretion and the level of total blood cholesterol (R = 0.36, p = 0.01).

Conclusion: Data were obtained on a more powerful inflammatory potential of peripheral blood monocytes in patients with early rheumatoid arthritis in the case of detection of the subclinical carotid atherosclerosis.

About the authors

Elena V. Gerasimova

V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia, 34А, Kashirskoye shose, Moscow 115522

Email: gerasimovaev@list.ru
ORCID iD: 0000-0001-5815-561X
Scopus Author ID: 57195540722
ResearcherId: T-6043-2017

PhD, Senior researcher of department of systemic rheumatic diseases V.A. Nasonova Research Institute of Rheumatology, Russian Federation, 34А, Kashirskoye shose, Moscow 115522

Russian Federation, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia, 34А, Kashirskoye shose, Moscow 115522

Irina G. Kirillova

V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia, 34А, Kashirskoye shose, Moscow 115522

Email: gerasimovaev@list.ru
ORCID iD: 0000-0002-1003-2087

Candidate of Medical Sciences, Researcher at the Department of Systemic Rheumatic Diseases

Russian Federation, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia, 34А, Kashirskoye shose, Moscow 115522

Maria V. Shalygina

V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia, 34А, Kashirskoye shose, Moscow 115522

Email: gerasimovaev@list.ru
ORCID iD: 0000-0002-2947-7334

Researcher at the Department of Systemic Rheumatic Diseases

Russian Federation, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia, 34А, Kashirskoye shose, Moscow 115522

Tatiana Popkova

V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia, 34А, Kashirskoye shose, Moscow 115522

Author for correspondence.
Email: gerasimovaev@list.ru
ORCID iD: 0000-0001-5793-4689

PhD, Head of the department of systemic rheumatic diseases V.A. Nasonova Research Institute of Rheumatology

Russian Federation, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia, 34А, Kashirskoye shose, Moscow 115522

References

  1. Bogatyreva A.I., Gerasimova E.V., Kirichenko T.V., Markina Yu.V., Popkova T.V., Shalygina M.V., Tolstik T.V., Markin A.M., Orekhov A.N. Pro-inflammatory activation of monocytes in patients with immunoinflammatory rheumatic diseases. Rheumatology Science and Practice. 2023;61(6):744-750. (In Russ.) doi: 10.47360/1995-4484-2023-744-750
  2. Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJL, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Södergren A, Wallberg Jonsson S, Van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, De Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DPM, Nurmohamed MT. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017;76(1):17-28. doi: 10.1136/ANNRHEUMDIS-2016-209775.
  3. Alivernini S, MacDonald L, Elmesmari A, Finlay S, Tolusso B, Gigante MR, Petricca L, Di Mario C, Bui L, Perniola S, Attar M, Gessi M, Fedele AL, Chilaka S, Somma D, Sansom SN, Filer A, McSharry C, Millar NL, Kirschner K, Nerviani A, Lewis MJ, Pitzalis C, Clark AR, Ferraccioli G, Udalova I, Buckley CD, Gremese E, McInnes IB, Otto TD, Kurowska-Stolarska M. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat Med. 2020;26(8):1295-1306. doi: 10.1038/s41591-020-0939-8.
  4. Ambarus CA, Noordenbos T, de Hair MJH, Tak PP, Baeten DLP. Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitis. Arthritis Res Ther. 2012;14(2):R74. doi: 10.1186/ar3796.
  5. Bashir S, Sharma Y, Elahi A, Khan F. Macrophage polarization: the link between inflammation and related diseases. Inflammation Research. 2016;65(1):1-11. doi: 10.1007/s00011-015-0874-1.
  6. Brühl H, Cihak J, Plachý J, Kunz-Schughart L, Niedermeier M, Denzel A, Gomez MR, Talke Y, Luckow B, Stangassinger M, Mack M. Targeting of Gr-1 +, CCR2+ monocytes in collagen-induced arthritis. Arthritis Rheum. 2007;56(9):2975-2985. doi: 10.1002/art.22854.
  7. Deng C, Zhang Q, He P, Zhou B, He K, Sun X, Lei G, Gong T, Zhang Z. Targeted apoptosis of macrophages and osteoclasts in arthritic joints is effective against advanced inflammatory arthritis. Nat Commun. 2021;12(1):2174. doi: 10.1038/s41467-021-22454-z.
  8. Dijkshoorn B, Raadsen R, Nurmohamed MT. Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022. J Clin Med. 2022;11(10). doi: 10.3390/JCM11102704.
  9. Hee Koh J, Jun Yoon S, Kim M, Cho S, Lim J, Park Y, Kim H-S, Won Kwon S, Kim W-U. Lipidome profile predictive of disease evolution and activity in rheumatoid arthritis. Exp Mol Med . 2022;54(2):143-155. doi: 10.1038/s12276-022-00725-z.
  10. Komatsu N, Takayanagi H. Mechanisms of joint destruction in rheumatoid arthritis — immune cell–fibroblast–bone interactions. Nat Rev Rheumatol. 2022;18(7):415-429. doi: 10.1038/s41584-022-00793-5.
  11. Kuuliala K, Kuuliala A, Hämäläinen M, Koivuniemi R, Kautiainen H, Moilanen E, Repo H, Leirisalo-Repo M. Impaired Akt Phosphorylation in Monocytes of Patients with Rheumatoid Arthritis. Scand J Immunol. 2017;85(2):155-161. doi: 10.1111/SJI.12521.
  12. Li H, Cao Z, Wang L, Liu C, Lin H, Tang Y, Yao P. Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation. Front Immunol. 2022;13:843712. doi: 10.3389/fimmu.2022.843712.
  13. Linton MF, Moslehi JJ, Babaev VR. Akt signaling in macrophage polarization, survival, and atherosclerosis. Int J Mol Sci. 2019;20(11):2703. doi: 10.3390/ijms20112703.
  14. McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. The Lancet. 2017;389(10086):2328-2337. doi: 10.1016/S0140-6736(17)31472-1.
  15. Nikiforov NG, Wetzker R, Kubekina M V., Petukhova A V., Kirichenko T V., Orekhov AN. Trained circulating monocytes in atherosclerosis: Ex vivo model approach. Front Pharmacol. 2019;10(JUN):725. doi: 10.3389/fphar.2019.00725.
  16. Ross EA, Devitt A, Johnson JR. Macrophages: The Good, the Bad, and the Gluttony. Front Immunol. 2021;12:708186. doi: 10.3389/fimmu.2021.708186.
  17. Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi A, Afshari JT, Sahebkar A. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425-6440. doi: 10.1002/jcp.26429.
  18. Stöger JL, Gijbels MJJ, van der Velden S, Manca M, van der Loos CM, Biessen EAL, Daemen MJAP, Lutgens E, de Winther MPJ. Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis. 2012;225(2):461-468. doi: 10.1016/j.atherosclerosis.2012.09.013.
  19. Tabas I, Bornfeldt KE. Macrophage Phenotype and Function in Different Stages of Atherosclerosis. Circ Res. 2016;118(4):653-667. doi: 10.1161/CIRCRESAHA.115.306256.
  20. Tu J, Wang X, Gong X, Hong W, Han D, Fang Y, Guo Y, Wei W. Synovial Macrophages in Rheumatoid Arthritis: The Past, Present, and Future. Mediators Inflamm. 2020;2020:1583647. doi: 10.1155/2020/1583647.
  21. Winchester R, Giles JT, Nativ S, Downer K, Zhang H-Z, Bag-Ozbek A, Zartoshti A, Bokhari S, Bathon JM. Association of Elevations of Specific T Cell and Monocyte Subpopulations in Rheumatoid Arthritis With Subclinical Coronary Artery Atherosclerosis. Arthritis & Rheumatology . 2016;68(1):92-102. doi: 10.1002/art.39419.
  22. Wymann MP, Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol. 2008;9(2):162-176. doi: 10.1038/nrm2335.
  23. Yang S, Yuan HQ, Hao YM, Ren Z, Qu SL, Liu LS, Wei DH, Tang ZH, Zhang JF, Jiang ZS. Macrophage polarization in atherosclerosis. Clinica Chimica Acta. 2020;501:142-146. doi: 10.1016/j.cca.2019.10.034.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Gerasimova E., Kirillova I., Shalygina M., Popkova T.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies